These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5321791)

  • 21. [Allogeneic bone marrow transplantation in malignant blood diseases].
    Ruutu T
    Nord Med; 1995; 110(12):310-3. PubMed ID: 8524630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation.
    Choudhry VP
    Indian Pediatr; 1997 Jun; 34(6):505-17. PubMed ID: 9357206
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of malignant haematological diseases: from maximally tolerated to minimally required?
    de Pauw BE
    Curr Opin Oncol; 2006 Nov; 18(6):648-51. PubMed ID: 16988589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Animal models for intractable hematologic disorders].
    Ikehara S
    Rinsho Ketsueki; 1994 May; 35(5):446-53. PubMed ID: 8028191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction: from the genetic basis of blood disorders to gene transfer for the purpose of gene therapy.
    Luzzatto L
    Semin Hematol; 1998 Apr; 35(2):89-92. PubMed ID: 9565151
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
    Gratwohl A
    Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What's new in pediatric hematology? (author's transl)].
    Schaison G
    Ann Pediatr (Paris); 1982 Apr; 29(4):296-300. PubMed ID: 7046599
    [No Abstract]   [Full Text] [Related]  

  • 28. [Urological and nephrological complications in diseases of the blood system].
    Epifanov NS; Papikian AI
    Urol Nefrol (Mosk); 1993; (4):49-52. PubMed ID: 8310571
    [No Abstract]   [Full Text] [Related]  

  • 29. Minimal residual disease post-bone marrow transplantation for hemato-oncological diseases.
    Toren A; Rechavi G; Nagler A
    Stem Cells; 1996 May; 14(3):300-11. PubMed ID: 8724696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood transfusion and cancerology].
    Bosset JF
    Soins; 1981 May; 26(10):31-5. PubMed ID: 7020083
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recent progress on peripheral blood stem cell transplantation].
    Harada M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):605. PubMed ID: 8963761
    [No Abstract]   [Full Text] [Related]  

  • 32. Transplantation.
    Curr Opin Oncol; 1997 Mar; 9(2):B41-7. PubMed ID: 9161802
    [No Abstract]   [Full Text] [Related]  

  • 33. Our first experience of transfusion support in allogenic bone marrow transplantations.
    Fregatova L; Volkova O; Platonova G; Afanasiev B
    Beitr Infusionsther Transfusionsmed; 1994; 32():445-7. PubMed ID: 9422124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Current Issues in Hematology 2002" continuing education course--review and prospects for the future].
    Demeter J
    Magy Onkol; 2003; 47(2):221-2. PubMed ID: 14655687
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation for the treatment of hematologic diseases: status in 1994.
    Beatty PG
    Exp Hematol; 1995 Mar; 23(3):277-88. PubMed ID: 7875245
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
    Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3530. PubMed ID: 8540085
    [No Abstract]   [Full Text] [Related]  

  • 37. Tuberculosis among allogeneic bone marrow transplant recipients in India.
    George B; Mathews V; Srivastava V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2001 May; 27(9):973-5. PubMed ID: 11436108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood and marrow transplant: it's not just for cancer.
    Eisenberg S
    ONS Connect; 2012 Nov; 27(11):22. PubMed ID: 23316526
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular biology and clinical study of hematologic diseases].
    Saito H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1371-9. PubMed ID: 8537737
    [No Abstract]   [Full Text] [Related]  

  • 40. Biotherapy in hematology: the next decade.
    Quesenberry PJ
    Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.